华东医药:持续稳健的经营-基础柱状图-数据可视化

华东医药(000963),全称华东医药股份有限公司(Huadong Medicine Co., Ltd.),主营业务为药品、中药材、中成药、医疗器械、化学试剂、玻璃仪器等六大类医药商品。,位于浙江杭州市,董事长为吕梁,总经理为吕梁。网址为www.eastchinapharm.com。

《华东医药:持续稳健的经营》华东医药股份有限公司创立于浙江杭州,主营业务是药品、中药材、中成药、医疗器械、化学试剂、玻璃仪器等六大类医药商品。华东医药拥有数十年正规经营打硬仗,财务报表也备受关注。未分配利润数据显示,华东医药自2012年以来,收入总额持续增长,其中2019年收入为7.66亿元,2020年收入为9.85亿元,增长了28%,令人印象深刻。从2013年以来,未分配利润一直保持良好增长态势,令人满意。总体而言,华东医药经营状况良好并且得到了长久的稳定发展。公司卓越的经营管理以及精准的战略部署,将其打造成为一家以创新的商业模式、雄厚的财务实力、营运能力和良好的企业声誉而著称的知名企业。作为浙江本土的医药行业领跑者,华东医药已经在今后的发展中取得了显著成就,朝着经营更加稳健的目标不断前进。

华东医药股份有限公司(000963)是一家总部位于浙江杭州市的医药企业,从事药品、中药材、中成药、医疗器械、化学试剂、玻璃仪器等商品的经营经营。华东医药继续保持良好的经营状况,长期的未分配利润净额不断增加。,"000963","华东医药","Huadong Medicine","吕梁","吕梁","ESG 300","国证A指","沪深300","巨潮大盘","深成指R","深市精选","深证100","深证100R","深证300","深证成指","深证责任","深证治理","中证新兴","数据可视化","上市公司财报","数据分析","基础柱状图","花火数图","图表"

我也要免费做基础柱状图

华东医药股份有限公司(000963)是一家总部位于浙江杭州市的医药企业,从事药品、中药材、中成药、医疗器械、化学试剂、玻璃仪器等商品的经营经营。华东医药继续保持良好的经营状况,长期的未分配利润净额不断增加。,"000963","华东医药","Huadong Medicine","吕梁","吕梁","ESG 300","国证A指","沪深300","巨潮大盘","深成指R","深市精选","深证100","深证100R","深证300","深证成指","深证责任","深证治理","中证新兴","数据可视化","上市公司财报","数据分析","基础柱状图","花火数图","图表"

我也要免费做基础柱状图

报表日期未分配利润
2022123113,488,021,239.94
2021123111,625,794,001.46
202012319,852,441,590.56
201912317,668,434,642.62
201812315,453,970,525.96
201712313,987,313,404.87
201612312,998,888,532.03
201512312,272,483,685.44
201412311,619,930,023.85
201312311,942,939,177.78
201212311,412,400,067.16
20111231976,718,100.64
20101231634,305,166.89
20091231589,949,512.74
20081231230,405,071.21
2007123161,795,329.46
2006123177,512,006.03
2005123153,157,125.35
2004123133,782,409.63
2003123134,968,595.73
2002123113,079,194.11
2001123140,792,213.47
200012311,381,898.48
199912311,322,089.70
1999063024,369,656.82
199812312,695,632.70
19971231684,812.51

我也要免费做基础柱状图